Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

Phase 1/2 Unknown 40 enrolled Stem Cells Arabia

NaSingle-groupOpen-labelTreatment

Summary

Herein, the investigators study the safety and efficacy of transplanting purified autologous bone marrow-derived stem cells transplanted via the intrathecal route by interventional radiology and the intravenous route.

Timeline

Start: 2016-09
Primary completion: 2019-01
Completion: 2019-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rexlemestrocel-L	Cell therapy	—	Intravenous

Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

Summary

Timeline

Drugs

Indications